ApopLogic Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

ApopLogic General Information

Description

Operator of a biopharmaceutical company intended to focus on developing and commercializing novel cancer therapeutics. The company focused on the development and commercialization of Breceptin, an oncolytic drug for the treatment of a wide range of solid tumors, which induces cancer cell apoptosis by targeting specific receptors on the surface of the tumor cells, enabling patients to provide treatment of cancers and a unique oncolytic drug.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12635 East Montview Boulevard
  • Suite 100
  • Aurora, CO 80045
  • United States
+1 (720)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 12635 East Montview Boulevard
  • Suite 100
  • Aurora, CO 80045
  • United States
+1 (720)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ApopLogic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Jan-2018 Completed Clinical Trials - General
4. Grant 31-Aug-2009 Completed Startup
3. Angel (individual) 11-Mar-2009 Completed Startup
2. Grant 24-Aug-2006 $10K Completed Startup
1. Grant 01-Jan-2006 $665K Completed Startup
To view ApopLogic’s complete valuation and funding history, request access »

ApopLogic Patents

ApopLogic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140294754-A1 Use of tumor fas expression to determine response to anti-cancer therapy Active 14-Apr-2011
US-10352936-B2 Use of tumor fas expression to determine response to anti-cancer therapy Active 14-Apr-2011

ApopLogic Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Xandex Ventures Corporate Venture Capital Minority
Life Science Angels Angel Group Minority
University License Equity Holding Corporation Minority
InteractiveWest Corporation
U.S. Department of Health and Human Services Government
To view ApopLogic’s complete investors history, request access »

ApopLogic FAQs

  • When was ApopLogic founded?

    ApopLogic was founded in 2005.

  • Where is ApopLogic headquartered?

    ApopLogic is headquartered in Aurora, CO.

  • What industry is ApopLogic in?

    ApopLogic’s primary industry is Drug Discovery.

  • Is ApopLogic a private or public company?

    ApopLogic is a Private company.

  • What is ApopLogic’s current revenue?

    The current revenue for ApopLogic is .

  • How much funding has ApopLogic raised over time?

    ApopLogic has raised $795K.

  • Who are ApopLogic’s investors?

    Xandex Ventures, Life Science Angels, University License Equity Holding, InteractiveWest, and U.S. Department of Health and Human Services have invested in ApopLogic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »